A Review of Selective Laser Trabeculoplasty: "The Hype Is Real"

Tomislav Sarenac; Anela Bečić Turkanović; Peter Ferme; Tomaž Gračner

doi:10.3390/jcm11133879

A Review of Selective Laser Trabeculoplasty: "The Hype Is Real"

J Clin Med. 2022 Jul 4;11(13):3879. doi: 10.3390/jcm11133879.

Authors

Tomislav Sarenac^{1

2}, Anela Bečić Turkanović¹, Peter Ferme¹, Tomaž Gračner^{1

2}

Affiliations

¹ Department of Ophthalmology, University Medical Center Maribor, Ljubljanska 5, 2000 Maribor, Slovenia.
² Faculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia.

Abstract

Presently, there is no efficacious treatment for glaucomatous optic neuropathy; the current treatment is focused on lowering intraocular pressure (IOP). Studies have demonstrated the safety and efficacy of selective laser trabeculoplasty (SLT) in reducing the IOP in eyes with open-angle (OAG) glaucoma or ocular hypertension (OH). Moreover, the European Glaucoma Society has instated SLT as the first-line or adjunctive treatment in OAG or OH, reiterating its clinical significance. In this review, we outline the old and the new roles of SLT, with an emphasis on clinical practice, and look further into its renewed appeal and future developments.

Keywords: dropless treatment; glaucoma; intraocular pressure; laser treatment; trabecular meshwork.

Publication types

Review

Grants and funding

This research received no external funding. The grant for the open-access fee was funded by the University Medical Center Maribor, Slovenia.